Genç Yaş Akciğer Kanserlerinin Klinikopatolojik Özellikleri

GİRİŞ ve AMAÇ: Akciğer kanseri dünyada en sık görülen ve en ölümcül kanserlerden biridir. Sigara içmenin süresi ve miktarının akciğer kanseri gelişiminde etkin bir rol oynadığı bilinmektedir. Akciğer kanserleri genelde orta ileri yaşlarda sık görülmekle birlikte 40 yaş altında nispeten nadirdir. Biz çalışmamızda 40 yaşın altında iken akciğer kanserine yakalanan hastaların klinikopatolojik özelliklerini ortaya koymayı amaçladık. GEREÇ ve YÖNTEM: 2000-2015 yılları arasında Trakya üniversitesi tıp fakültesi tıbbi onkoloji polikliniğine başvuran hastalar retrospektif olarak tarandı ve 40 yaş altında iken akciğer kanseri tanısı alan hastalar çalışmaya dahil edildi. BULGULAR: Çalışma kriterlerine uyan 11 erkek 4 kadın toplam 15 hasta vardı. 10 hastanın özgeçmişinde sigara kullanımı vardı. Özgeçmişlerinde sigara kullanımı olanlarda ortalama genel genel sağkalım 7 ay olmayanlarda 43 aydı. TARTIŞMA ve SONUÇ: Çalışmamız 40 yaşın altında akciğer kanseri tanısı alan hastalarda, sigara içme öyküsünün bulunmasının kötü bir prognostik faktör olabileceğini göstermiştir.

Clinicopathological Characteristics of Young Age Lung Cancers

INTRODUCTION: Lung cancer is one of the most common and deadly cancer types in the world. It is known that the duration and amount of smoking plays an effective role in the development of lung cancer. Lung cancer most often occurs in middle-aged and elderly adults and is less often among people under the age of 40 years. In our study we tried to explain clinicopathologic features of patients who has lung cancer under the age of 40 years. METHODS: Between 2000 and 2015 patients who had lung cancer applied to Department of Medical Oncology of Trakya University Medical School were reviewed retrospectively and the patients who are under the age of 40 years were included to this study. RESULTS: 15 patients who had eligibility criteria were evaluated.11 of 15 patients were male. 10 patients had smoking history. Over all survival was 7 months for the patients who had smoking history and 43 months for others. DISCUSSION and CONCLUSION: Our study has shown that smoking history can be a poor prognostic factor for patients diagnosed with lung cancer under the age of 40 years.

PDF

___

1. Miller KD, Siegel RL, Lin CC, et al .Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin 2016, 66:271-289.
2. Travis WD, Brambilla E, Nicholson AG, et al . The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification. J Thorac Oncol 2015, 10:1243-1260.
3. Groth SS, Maddaus MA. Open lobectomy for patients with stage I non-small cell lung cancer. Thorac Surg Clin 2007, 17:203-215.
4. Ihde DC. Chemotherapy of lung cancer. N Engl J Med 1992, 327:1434-1441.
5. Tome WA, Welsh J, Fowler JF. The effect of fraction time in intensity modulated radiotherapy: theoretical and experimental evaluation of an optimization problem (the real conclusions): in regard to Mu et al. Radiotherapy on Oncology 2003; 68: 181-87. Radiother Oncol 2004, 72:113- 114; author reply 114-115.
6. Lynch TJ, Bell DW, Sordella R, et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-smallcell lung cancer to gefitinib. N Engl J Med 2004, 350:2129-2139.
7. Subramanian J, Govindan R. Lung cancer in never smokers: a review. J Clin Oncol 2007, 25:561-570.
8. Leone FT, Evers-Casey S, Toll BA, et al . Treatment of tobacco use in lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013, 143:e61S-77S.
9. Schwartz AG. Genetic predisposition to lung cancer. Chest 2004, 125:86s-89s.
10. Straif K, Benbrahim-Tallaa L, Baan R, et al. A review of human carcinogens--Part C: metals, arsenic, dusts, and fibres. Lancet Oncol 2009, 10:453-454.
11. Olsson AC, Gustavsson P, Kromhout H, et al